| Issue |
Title |
File |
| No 4 (2011) |
Time course of changes in the biochemical composition of peripheral lymph in breast cancer |
(Rus)
|
|
Gantsev S.K., Sultanbayev A.V., Ishmuratova R.S., Frolova V.Y., Kzyrgalin S.R.
|
| No 4 (2011) |
Intraductal papillomas of the breast. The problems of the pathogenesis, treatment, and prevention of intraductal carcinoma |
(Rus)
|
|
Khanafiyev G.K., Berzin S.A., Maltseva U.Y., Mazur A.E.
|
| No 2 (2011) |
Time course of changes in 6-sulfatoxymelatonin excretion in patients with breast cancer after various neoadjuvant chemotherapy options |
(Rus)
|
|
Sidorenko Y.S., Kit O.I., Lisutin A.E., Semiletkin O.M.
|
| No 4 (2010) |
The status of epidermal growth factor receptor and topoisomerase IIα genes in triple-negative breast cancer cells |
(Rus)
|
|
Karseladze D.A., Poddubnaya I.V., Karseladze A.I.
|
| No 4 (2010) |
Cytofluorometric characteristics of molecular subtypes of breast cancer |
(Rus)
|
|
Tsoi L.K., Bogatyrev V.N., Vysotskaya I.V., Letyagin V.P., Kim E.A.
|
| No 2 (2010) |
New technologies and possibilities of breast cancer staging by the criterion N ex vivo |
(Rus)
|
|
Gantsev S.K., Galeyev M.G., Ishmuratova R.S., Tursumetov D.S., Tikhonova V.Y., Sultanbayev A.V., Khusnutdinov S.M., Tatunov M.A., Zainullin F.S.
|
| No 2 (2010) |
The clinical value of p53 and the parameters of DNA-flow cytofluorometry in combination with clinical and morphological predictors in breast cancer |
(Rus)
|
|
Tsoi L.K., Bogatyrev V.N., Letyagin V.P., Vishnevskaya Y.V., Platova A.M.
|
| No 1 (2010) |
The specific features of cellular, humoral, and activation markers of the immune system and the biophysical parameters of superficial peripheral lymphocyte membranes in patients with breast cancer |
(Rus)
|
|
Alimkhodzhayeva L.T., Zikiryakhodzhayev A.D.
|
| No 1 (2010) |
Changes in angiogenesis markers during neoadjuvant treatment for locally advanced breast cancer |
(Rus)
|
|
Kim E.A., Vysotskaya I.V., Kushlinsky N.E., Letyagin V.P., Gershtein E.S.
|
| No 3-4 (2009) |
CLINICAL PERSPECTIVES FOR STUDYING THE NUCLEAR TRANSCRIPTION FACTOR NF-κB IN BREAST CANCER |
(Rus)
|
|
Gershtein E.S., Platova A.M., Letyagin V.P., Kushlinsky N.E.
|
| No 3-4 (2009) |
MEMBRANE LEc EXPRESSION IN BREAST CANCER CELLS |
(Rus)
|
|
Udalova Y.A., Bovin N.V., Obukhova P.S., Shilova N.V., Kovrigina A.M., Subbotina A.A., Timoshenko V.V., Galanina O.E., Kadagidze Z.G., Letyagin V.P., Tupitsyn N.N.
|
| No 3-4 (2009) |
DIAGNOSTIC VALUE OF STUDYING THE LEVELS OF PRO- AND ANTI-INFLAMMATORY CYTOKINES OF THE IMMUNE SYSTEM IN PATIENTS WITH BREAST CANCER |
(Rus)
|
|
Alimkhodjaeva L.T.
|
| No 4 (2008) |
IN VITRO EFFECTS OF CHEMICAL AGENTS ON BREAST TUMOR CELLS UNDER 24-HOUR INCUBATION |
(Rus)
|
|
Navruzov S.N., Alimkhodzhayeva L.T.
|
| No 4 (2008) |
ANALYSIS OF THE RESULTS OF NEODJUVANT TREATMENT IN PATIENTS WITH CONSIDERATION FOR THE IMMUNOPHENOTYPICAL FEATURES OF BREAST CANCER |
(Rus)
|
|
Subbotina A.A., Letyagin V.P., Tupitsyn N.N., Vysotskaya I.V., Yermilova V.D.
|
| No 3 (2008) |
CLINICAL AND IMMUNOLOGIC IMPORTANCE OF MDR1/PGP 170 EXPRESSION IN PATIENTS WITH BREAST CANCER |
(Rus)
|
|
Yengay D.A., Poddubnaya I.V., Tupitsin N.N., Mechetner Y.B.
|
| No 2 (2008) |
INDICES OF FREE RADICAL PROCESSES AND ANTIOXIDANT SYSTEM IN TUMOR TISSUE AND PERIFOCAL ZONE IN DIFFERENT CLINICAL VARIANTS OF BREAST CANCER |
(Rus)
|
|
Frantziyantz Y.M., Soldatkina N.V., Orlovskaya L.A., Dashkov A.V.
|
| No 2 (2008) |
IMMUNOMORPHOLOGIC CHANGES IN TUMOR TISSUE OF PATIENTS WITH BREAST CANCER INDUCED BY NEOADJUVANT CHEMOTHERAPY CARRIED OUT IN ARTIFICIALLY HYPERGLYCEMIC STATE |
(Rus)
|
|
Alimkhodzhayeva L.T.
|
| No 1 (2008) |
CLINICAL SIGNIFICANCE OF THE VEGFR-2 IN THE TUMORS AND BLOOD SERA OF THE BREAST CANCER PATIENTS |
(Rus)
|
|
Kim E.A., Platova A.M., Visotzkaya I.V., Gershteyn E.S., Letyagin V.P., Kushlinskiy N.E., Mironova E.E.
|
| 1 - 18 of 18 Items |
|
